Experience with hydroxyurea as a radiosensitizer in carcinoma of the cervix

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Since 1968, hydroxyurea has been used as a radiosensitizer in combination modality treatments for carcinoma of the cervix. The drug has shown an advantage over placebo in several randomized trials. Although hydroxyurea is given orally on an outpatient basis, it has not gained widespread acceptance. Previous reports are reviewed and possible future uses are discussed.

Original languageEnglish
Pages (from-to)48-52
Number of pages5
JournalSeminars in Oncology
Volume19
Issue number3 SUPPL. 9
StatePublished - 1992

Fingerprint

Hydroxyurea
Cervix Uteri
Carcinoma
Outpatients
Placebos
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Oncology

Cite this

Experience with hydroxyurea as a radiosensitizer in carcinoma of the cervix. / Stehman, Frederick.

In: Seminars in Oncology, Vol. 19, No. 3 SUPPL. 9, 1992, p. 48-52.

Research output: Contribution to journalArticle

@article{605a7c96e3664c858c0db52985b8579e,
title = "Experience with hydroxyurea as a radiosensitizer in carcinoma of the cervix",
abstract = "Since 1968, hydroxyurea has been used as a radiosensitizer in combination modality treatments for carcinoma of the cervix. The drug has shown an advantage over placebo in several randomized trials. Although hydroxyurea is given orally on an outpatient basis, it has not gained widespread acceptance. Previous reports are reviewed and possible future uses are discussed.",
author = "Frederick Stehman",
year = "1992",
language = "English",
volume = "19",
pages = "48--52",
journal = "Seminars in Oncology",
issn = "0093-7754",
publisher = "W.B. Saunders Ltd",
number = "3 SUPPL. 9",

}

TY - JOUR

T1 - Experience with hydroxyurea as a radiosensitizer in carcinoma of the cervix

AU - Stehman, Frederick

PY - 1992

Y1 - 1992

N2 - Since 1968, hydroxyurea has been used as a radiosensitizer in combination modality treatments for carcinoma of the cervix. The drug has shown an advantage over placebo in several randomized trials. Although hydroxyurea is given orally on an outpatient basis, it has not gained widespread acceptance. Previous reports are reviewed and possible future uses are discussed.

AB - Since 1968, hydroxyurea has been used as a radiosensitizer in combination modality treatments for carcinoma of the cervix. The drug has shown an advantage over placebo in several randomized trials. Although hydroxyurea is given orally on an outpatient basis, it has not gained widespread acceptance. Previous reports are reviewed and possible future uses are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0026704782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026704782&partnerID=8YFLogxK

M3 - Article

C2 - 1641657

AN - SCOPUS:0026704782

VL - 19

SP - 48

EP - 52

JO - Seminars in Oncology

JF - Seminars in Oncology

SN - 0093-7754

IS - 3 SUPPL. 9

ER -